6826 - 6850 of 7916 Results
Title
Year
- Temporal profile of improvement of tardive dystonia after globus pallidus deep brain stimulation2014OPENTitle: Temporal profile of improvement of tardive dystonia after globus pallidus deep brain stimulationJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 21Issue #: 2Start Page: 116End Page: 119Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.11.013Best OA location URL: https://europepmc.org/articles/pmc4879955?pdf=renderCitation Count: 28
-
OPENTitle: Clinical Correlations With Lewy Body Pathology inLRRK2-Related Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 72Issue #: 1Start Page: 100End Page: 100Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.2704Best OA location URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399368/pdf/nihms-678094.pdfCitation Count: 285
-
OPENTitle: Higher Frequency of Certain Cancers inLRRK2G2019S Mutation Carriers With Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 72Issue #: 1Start Page: 58End Page: 58Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.1973Best OA location URL: https://europepmc.org/articles/pmc4366130?pdf=renderCitation Count: 86
- Novel Para-Phenyl Substituted Diindolylmethanes Protect Against MPTP Neurotoxicity and Suppress Glial Activation in a Mouse Model of Parkinson’s Disease2014OPENTitle: Novel Para-Phenyl Substituted Diindolylmethanes Protect Against MPTP Neurotoxicity and Suppress Glial Activation in a Mouse Model of Parkinson’s DiseaseJournal Name: Toxicological SciencesPublisher: Oxford University Press (OUP)Vol: 143Issue #: 2Start Page: 360End Page: 373Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/toxsci/kfu236Best OA location URL: https://academic.oup.com/toxsci/article-pdf/143/2/360/10915824/kfu236.pdfCitation Count: 43
-
OPENTitle: Clinical markers for identifying cholinergic deficits in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 2Start Page: 269End Page: 273Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26061Best OA location URL: https://europepmc.org/articles/pmc4318774?pdf=renderCitation Count: 55
-
OPENTitle: The relationship between obsessive‐compulsive symptoms and PARKIN genotype: The CORE‐PD studyJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 2Start Page: 278End Page: 283Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26065Best OA location URL: https://europepmc.org/articles/pmc4318772?pdf=renderCitation Count: 16
-
RESTRICTEDTitle: Microglial and macrophage polarization—new prospects for brain repairJournal Name: Nature Reviews NeurologyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 56End Page: 64Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nrneurol.2014.207Best OA location URL: https://europepmc.org/articles/pmc4395497?pdf=renderCitation Count: 1040
- MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320a2014OPENTitle: MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320aJournal Name: Journal of NeuroimmunologyPublisher: Elsevier BVVol: 278Issue #:Start Page: 185End Page: 189Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jneuroim.2014.11.004Best OA location URL: https://europepmc.org/articles/pmc4297694?pdf=renderCitation Count: 61
-
RESTRICTEDTitle: Neuroimaging biomarkers for Parkinson disease: Facts and fantasyJournal Name: Annals of NeurologyPublisher: WileyVol: 76Issue #: 6Start Page: 769End Page: 783Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.24291Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.24291Citation Count: 39
- Phosphorylation by PINK1 Releases the UBL Domain and Initializes the Conformational Opening of the E3 Ubiquitin Ligase Parkin2014OPENTitle: Phosphorylation by PINK1 Releases the UBL Domain and Initializes the Conformational Opening of the E3 Ubiquitin Ligase ParkinJournal Name: PLoS Computational BiologyPublisher: Public Library of Science (PLoS)Vol: 10Issue #: 11Start Page: e1003935End Page: e1003935Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pcbi.1003935Best OA location URL: https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1003935&type=printableCitation Count: 105
-
OPENTitle: Analysis of COQ2gene in multiple system atrophyJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/1750-1326-9-44Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/1750-1326-9-44Citation Count: 44
- Dopaminergic Neurotoxicants Cause Biphasic Inhibition of Purinergic Calcium Signaling in Astrocytes2014OPENTitle: Dopaminergic Neurotoxicants Cause Biphasic Inhibition of Purinergic Calcium Signaling in AstrocytesJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 11Start Page: e110996End Page: e110996Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0110996Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0110996&type=printableCitation Count: 11
- Latent growth-curve analysis reveals that worsening Parkinson’s disease quality of life is driven by depression.2014OPENTitle: Latent growth-curve analysis reveals that worsening Parkinson’s disease quality of life is driven by depression.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 29Issue #: 4Start Page: 603End Page: 609Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1037/neu0000158Best OA location URL: https://europepmc.org/articles/pmc5036570?pdf=renderCitation Count: 19
-
RESTRICTEDTitle: Antibodies and protein misfolding: From structural research tools to therapeutic strategiesJournal Name: Biochimica et Biophysica Acta (BBA) - Proteins and ProteomicsPublisher: Elsevier BVVol: 1844Issue #: 11Start Page: 1907End Page: 1919Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.bbapap.2014.08.016Best OA location URL: https://doi.org/10.1016/j.bbapap.2014.08.016Citation Count: 58
- Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging2014OPENTitle: Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimagingJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 10Issue #: 6Start Page: 779End Page: 789Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2014.09.001Best OA location URL: https://europepmc.org/articles/pmc4273919?pdf=renderCitation Count: 27
-
RESTRICTEDTitle: Medicines for the Mind: Policy-Based “Pull” Incentives for Creating Breakthrough CNS DrugsJournal Name: NeuronPublisher: Elsevier BVVol: 84Issue #: 3Start Page: 554End Page: 563Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2014.10.027Best OA location URL: http://www.cell.com/article/S0896627314009477/pdfCitation Count: 64
-
RESTRICTEDTitle: The Future of Research in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 71Issue #: 11Start Page: 1351End Page: 1351Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.1717Citation Count: 31
- Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site study2014OPENTitle: Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site studyJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 2Start Page: 1097End Page: 1104Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.10.029Best OA location URL: https://europepmc.org/articles/pmc4315708?pdf=renderCitation Count: 137
-
OPENTitle: LRRK2 Transport Is Regulated by Its Novel Interacting Partner Rab32Journal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 10Start Page: e111632End Page: e111632Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0111632Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0111632&type=printableCitation Count: 87
-
RESTRICTEDTitle: Design, synthesis, and evaluation of a selective chemosensor for leucine-rich repeat kinase 2Journal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 24Issue #: 24Start Page: 5648End Page: 5651Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2014.10.079Citation Count: 8
- Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits2014OPENTitle: Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficitsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 74Issue #:Start Page: 66End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2014.10.016Best OA location URL: https://europepmc.org/articles/pmc4505366?pdf=renderCitation Count: 138
-
OPENTitle: Spinal Cord Stimulation Alleviates Motor Deficits in a Primate Model of Parkinson DiseaseJournal Name: NeuronPublisher: Elsevier BVVol: 84Issue #: 4Start Page: 716End Page: 722Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2014.08.061Best OA location URL: http://www.cell.com/article/S0896627314008964/pdfCitation Count: 102
- Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy Pathology2014OPENTitle: Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy PathologyJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 2Issue #: 1Start Page: 33End Page: 38Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12104Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12104Citation Count: 2
- Role for NUP62 depletion and PYK2 redistribution in dendritic retraction resulting from chronic stress2014OPENTitle: Role for NUP62 depletion and PYK2 redistribution in dendritic retraction resulting from chronic stressJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 111Issue #: 45Start Page: 16130End Page: 16135Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1418896111Best OA location URL: https://www.pnas.org/content/pnas/111/45/16130.full.pdfCitation Count: 46
- Effects of Tyrosine on Parkinson's Disease: A Randomized, Double‐Blind, Placebo‐Controlled Trial2014OPENTitle: Effects of Tyrosine on Parkinson's Disease: A Randomized, Double‐Blind, Placebo‐Controlled TrialJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 1Issue #: 4Start Page: 348End Page: 353Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12082Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12082Citation Count: 11